Download PDF
Synthesis 2005(19): 3202-3208  
DOI: 10.1055/s-2005-918437
PAPER
© Georg Thieme Verlag Stuttgart · New York

A Novel Synthetic Route to Cytotoxic 1,4-Anthraquinones from 1,4-Benzoquinones

Mª Angeles Castro*a, José Mª Miguel del Corrala, Marina Gordalizaa, Pablo A. Garcíaa, Ana Mª Gamitoa, Simone A. Gualbertob, Ronan Batistab, Arturo San Felicianoa
a Departamento de Química Farmacéutica, Facultad de Farmacia, Universidad de Salamanca, 37007 Salamanca, Spain
b Faculdade de Farmácia, Dpto. Productos Farmacêuticos, Universidade Federal de Minas Gerais, Cep. 30180, 112 Belo Horizonte-MG, Brazil
Fax: +34(9230)294515; e-Mail: macg@usal.es;
Further Information

Publication History

Received 14 April 2005
Publication Date:
27 October 2005 (online)

    Permissions and Reprints All articles of this category

Abstract

A new procedure to obtain anthracene-1,4-diones from p-benzoquinones and myrcene, in the presence of acids, is described. The cycloaddition reaction between α-myrcene and p-benzoquinones, followed by oxidation, led to 1,4-naphthoquinones or 1,4-anthraquinones depending upon whether the Lewis acid used in the Diels-Alder reaction, was present or absent during oxidation; furthermore, traces of acid in the solvents played an important role in determining the cycloadduct obtained. The quinones synthesized exhibited cytotoxicity towards several tumor cell lines.

Key words

1,4-naphthoquinones - anthracene-1,4-diones - 1,4-anthraquinones - Diels-Alder addition - cytotoxicity

    References

  • 1a Cancer Chemotherapeutic Agents   Foye WO. ACS; Washington D.C.: 1995. 
    Google Scholar
  • 1b Monks TJ. Hanzlik RP. Cohen GM. Ross D. Graham DG. Toxicol. Appl. Pharmacol.  1992,  112:  2 
    Google Scholar
  • 1c O’Brien PJ. Chem.-Biol. Interact.  1991,  80:  1 
    Google Scholar
  • 2a Mäntyla A. Garnier T. Rautio J. Nevalainen T. Vepsälainen J. Koskinen A. Croft SL. Järvinen T. J. Med. Chem.  2004,  47:  188 
    CrossrefGoogle Scholar
  • 2b Pisani DE. Elliott AJ. Hinman DR. Aaronson LM. Pardini RS. Biochem. Pharmacol.  1986,  35:  3791 
    CrossrefGoogle Scholar
  • 3 Thomson RH. Naturally Occurring Quinones IV. Recent Advances   Blackie Academic & Professional; London U.K: 1997. 
    Google Scholar
  • 4a Pessoa ODL. Lemos TLG. Carvalho MG. Braz-Filho R. Phytochemistry  1995,  40:  1777 
    CrossrefGoogle Scholar
  • 4b Rustaiyan A. Samadizadeh M. Habibi Z. Jakupovic J. Phytochemistry  1995,  39:  163 
    CrossrefGoogle Scholar
  • 4c Marques WB. Dos Santos HS. Pessoa ODL. Braz-Filho R. Lemos TLG. Phytochemistry  2000,  55:  793 
    CrossrefGoogle Scholar
  • 4d Pessoa C. Silveira ER. Lemos TLG. Wetmore LA. Moraes MO. Leyva A. Phytother. Res.  2000,  14:  187 
    CrossrefGoogle Scholar
  • 5a Fariña F. Noheda P. Paredes MC. J. Org. Chem.  1993,  58:  7406 
    CrossrefGoogle Scholar
  • 5b Barranco E. Martin N. Segura JL. Seoane C. Cruz P. Langa F. Gonzalez A. Pingarron JM. Tetrahedron  1993,  49:  4881 
    CrossrefGoogle Scholar
  • 5c Cameron DW. Griffiths PG. Riches AG. Aust. J. Chem.  1999,  52:  1173 
    CrossrefGoogle Scholar
  • 6a Majumdar G. Murty KVSN. Mal D. Tetrahedron Lett.  1994,  35:  6139 
    CrossrefGoogle Scholar
  • 6b Laugraud S. Guingant A. D’Angelo J. Tetrahedron Lett.  1992,  33:  1289 
    CrossrefGoogle Scholar
  • 7 Leyva A. Pessoa C. Boogaerdt F. Sokaroski R. Lemos TLG. Wermore LA. Huruta RR. Moraes MO. Anticancer Res.  2000,  20:  1029 
    Google Scholar
  • 8a Wu M. Wang B. Perchellet EM. Sperfslage BJ. Stephany HA. Hua DY. Perchellet JP. Anti-Cancer Drugs  2001,  12:  807 
    CrossrefGoogle Scholar
  • 8b Perchellet EM. Magill MJ. Huang X. Dalke DM. Hua DY. Perchellet JP. Anti-Cancer Drugs  2000,  11:  339 
    CrossrefGoogle Scholar
  • 9 Perchellet EM. Wang Y. Weber RL. Sperfslage BJ. Lou K. Crossland J. Hua DY. Perchellet JP. Biochem. Pharmacol.  2004,  67:  523 
    CrossrefGoogle Scholar
  • 10 Wurm G. Probst R. Schwandt S. Pharmazie  2001,  56:  7 
    Google Scholar
  • 11a Miguel del Corral J. M., Gordaliza M., Castro M. A., Mahiques M. M., Chamorro P., Molinari A., García-Grávalos M. D., Broughton H. B., San Feliciano A.; J. Med. Chem.; 2001, 44: 1257
    Crossref
  • 11b Miguel del Corral JM. Gordaliza M. Castro MA. Mahiques MM. San Feliciano A. García-Grávalos MD. Bioorg. Med. Chem.  1998,  6:  31 
    CrossrefGoogle Scholar
  • 11c Molinari A. Oliva A. Aguilera N. Miguel del Corral JM. Castro MA. Gordaliza M. García-Grávalos MD. San Feliciano A. Bioorg. Med. Chem.  2000,  8:  1027 
    CrossrefGoogle Scholar
  • 12 Araya-Maturana R. Cassels BK. Delgado-Castro T. Valderrama JA. Weiss-López BE. Tetrahedron  1999,  55:  637 
    CrossrefGoogle Scholar
  • 13 Miguel del Corral JM. Castro MA. Gordaliza M. Martín ML. Oliveira AB. Gualberto SA. García-Grávalos MD. San Feliciano A. Arch. Pharm. Pharm. Med. Chem.  2002,  335:  427 
    CrossrefGoogle Scholar